Slater & Gordon: A faintly familiar story continues

More revenue growth, but profit falls

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Slater & Gordon Limited (ASX: SGH) published its preliminary full year results on Friday. Even though revenues were up 19.4% to $218m, net profit dropped by 10% to $25m. Management's view was that if the Vioxx class action failure was excluded, normalised profit actually increased.  Shareholders should be relieved, given the number of large acquisitions that have taken place.

Low Cashflow

Operating cashflow deteriorated to $15m, and cash from investing activities chewed up a massive $70m.  Finance costs totals $6.8m for the full year.  Yet curiously enough, despite this cashflow situation, Slater & Gordon will pay significant dividends again.  The following is a table summarising the cashflow situation for the last five years.

  2007 2008 2009 2010 2011 2012
Revenue 63 79.7 103 122 178 214
NPAT 10.6 15 17 19.8 27.9 25
Operating Cashflow 8.5 11.5 -0.7 24.7 20 15
Free Cashflow 4 -3 -11 9 -47 -55

Increasing Debt

Once again, the latest cashflow deficiency was plugged by an increase in borrowings.  The total liabilities of are now $282m.  On the asset side of the balance sheet, there is $128m in accounts receivables, and $246 m comprising "Work-In-Progress".  With $15m of cashflow to cover $6.8m in finance costs, there really is not much room for error, and shareholders will hope that the costs of funding do not spiral out of control, and that debt rollover takes place smoothly.

ROE and ROIC versus Money in the bank

As at 30 June 2012, Slater & Gordon had total assets of $525m and net assets/equity of $243m. It made $15m in net profits.  This is about 2.85% per annum return on total assets, and 6.2% per annum return on equity.  At these rates of return, shareholders are not compensated for the additional risks involved.  Returns need to be at least double this to qualify as investment grade.

Foolish bottom line

Slater & Gordon has made its way into the good graces of Mr Market in the last six months.  Current prices imply a market valuation of about $320m for SGH, which is an increase of 28% in the last six months. We would prefer to watch this from a safe distance.

If you're in the market for some high yielding ASX shares, look no further than our "Secure Your Future with 3 Rock-Solid Dividend Stocks" report. In this free report, we've put together our best ideas for investors who are looking for solid companies with high dividends and good growth potential. Click here now to find out the names of our three favourite income ideas. But hurry – the report is free for only a limited time.

More reading

Motley Fool writer/analyst Peter Phan doesn't own shares in Slater & Gordon. The Motley Fool's purpose is to help the world invest, better. Take Stock is The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »